Taylor & Morgan Wealth Management, LLC Isoray, Inc. Transaction History

Taylor & Morgan Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	N/A	-375,000 Reduced 60.0%	250,000 $172,000
Q4 2023 Jan 10, 2024	BUY	N/A	50,000 Added 8.7%	625,000 $431,000
Q3 2023 Oct 05, 2023	SELL	N/A	-20,582 Reduced 3.46%	575,000 $396,000
Q2 2023 Jul 13, 2023	SELL	$0.0 - $0.69 $0 - $113,340	-164,261 Reduced 21.62%	595,582 $410,000
Q1 2023 Apr 06, 2023	SELL	$0.0 - $0.67 $0 - $7,042	-10,511 Reduced 1.36%	759,843 $486,000
Q3 2022 Oct 12, 2022	SELL	$0.22 - $0.43 $1,100 - $2,150	-5,000 Reduced 0.64%	770,354 $177,000
Q2 2022 Jul 08, 2022	BUY	$0.26 - $0.37 $58,592 - $83,380	225,354 Added 40.97%	775,354 $240,000
Q1 2022 Apr 18, 2022	BUY	$0.31 - $0.41 $65,100 - $86,100	210,000 Added 61.76%	550,000 $200,000
Q4 2021 Jan 21, 2022	BUY	$0.38 - $0.68 $129,200 - $231,200	340,000 New	340,000 $132,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Taylor & Morgan Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Taylor & Morgan Wealth Management, LLC with notifications on news.